PDF Antisickling and antibacterial activities of Uvariopsis congensis Robyns & Ghesq. (Annonanceae)

Télécharger Antibacterial article.pdf ( 773 KB)
Afficher Open in browser
Upload date 03 Oct 2016
Contributeur bienfait,Jean-Léon kambale
Couverture géographique Kisangani, R D Congo
Mots-clefs Sickle cell disease, Congo basin, great apes plant foods, zoopharmacognosy, novel drugs
Date de publication 09/12/2016
Toutes les versions
# Nom du fichier Contributeur Upload date Taille Type de contenu
1 Antibacterial article.pdf (actuel) bienfait,Jean-Léon kambale 03 Oct 2016 773 KB application/pdf

The aim of the present study was to evaluate the chemical composition and bioactivity of Uvariopsis congensis
Robyns & Ghesq. stem bark extract against Sickle cell disease and associated bacteria. This plant species
ingested by wild chimpanzees as medicinal food could inhibit the human hemoglobin S polymerization inducing
hemolysis of sickle erythrocytes (as it does by inhibiting the Plasmodium falciparum inducing hemolysis of
infected erythrocytes in great apes). The antisickling and antibacterial activities were assessed according
respectively to Emmel and micro-dilution methods. The results revealed that Uvariopsis congensis Robyns &
Ghesq. stem bark extract contains various secondary metabolites such as alkaloids, saponins, total polyphenols
(87.942±0.536 µg GAE/g), flavonoids (0.623±0.630 µg QE/g), tannins (0889±0.002 µg TAE/g), anthocyanis
(0.150±0.017 µg M-3GE/g), leuco-anthocyanins, quinones, terpenes and steroids. Ethanolic extract displayed
interesting antisickling activity which was confirmed by the appearance of radius, the increase of the cell area
and the decrease of it perimeter (p<0.05). The antisickling activity of Uvariopsis congensis Robyns & Ghesq.
stem bark extract is dose dependent. The minimal concentration of normalization (MCN) and the dose of
extract for which 50% of the sickled erythrocytes are reversed (ED50) were 100 µg/mL and 0.6 µg/ml
respectively. The minimum inhibitory concentrations (MIC) were 250 µg/mL and 500 µg/mL respectively for
Escherichia coli ATCC 27195 and Staphylococcus aureus ATCC 33591. The bioactivity of this plant species
could be improved by liquid-liquid extraction and chromatographic bio-guided fractionation of ethanolic extract.
This study validates for the first time the in vitro antisickling activity of Uvariopsis congensis Robyns & Ghesq.
stem bark extract. The animal self-medication constitutes thus an innovative method which could lead to the
discovery of new drugs for the treatment of human ailments like Sickle cell disease.